CLARITHROMYCIN

CAS No.
81103-11-9
CCD No.
CCD00174169
Formula
C38 H69 N O13
MolWeight
747.957

Basic Information

Product Name: CLARITHROMYCIN
CAS: 81103-11-9
English Synonyms: INFEX ; CLAREM ; KLABAX ; FROMILID ; CLARITHROMYCINE ; CRIXAN ; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(DIMETHYLAMINO)-3-HYDROXY-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-14-ETHYL-12,13-DIHYDROXY-4-(((2R,4R,5S,6S)-5-HYDROXY-4-METHOXY-4,6-DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-7-METHOXY-3,5,7,9,11,13-HEXAMETHYLOXACYCLOTETRADECANE-2,10-DIONE ; CLARIPEN ; CLARIDAR ; 6-(4-DIMETHYLAMINO-3-HYDROXY-6-METHYLTETRAHYDROPYRAN-2-YL-OXY)-14-ETHYL-12,13-DIHYDROXY-4-(5-HYDROXY ; CLARI ; CLARITHROMYCIN ; CLACID ; VIKROL ; 6-O-METHYLERYTHROMYCIN ; KLACID ; KLARICID ; BIAXIN ; CLACEE
MDL Number.: MFCD00865140
H bond acceptor: 14
H bond donor: 4
Smile: CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
InChi: InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
InChiKey: InChIKey=AGOYDEPGAOXOCK-KCBOHYOISA-N

Property

Comments: BIOCHEM/PHYSIOL ACTIONS: CLARITHROMYCIN IS A MACROLIDE ANTIBIOTIC. IT PREVENTS BACTERIAL GROWTH BY INTERFERING WITH PROTEIN SYNTHESIS. CLARITHROMYCIN IS AN ACID-STABLE VERSION OF ERYTHROMYCIN AND IS PARTICULARLY EFFECTIVE AGAINST GRAM-NEGATIVE BACTERIA. IT HAS A SHORT HALF-LIFE, HOWEVER ITS METABOLITE, 14-HYDROXY CLARITHROMYCIN IS NEARLY TWICE AS ACTIVE AS CLARITHROMYCIN AGAINST CERTAIN BACTERIA
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

Safety information

* If the product has intellectual property rights, a license granted is must or contact us.